Roderike Pohl, VP Research at Biodel Inc (BIOD), sold 4,800 shares at $18.67 ($89K) on 2008-01-18, disclosed to the SEC on 2008-01-22.
Scheduled sale ($89k) by VP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.31 | 350 | $6K | 7.2% |
| 2 | $18.34 | 100 | $2K | 2.1% |
| 3 | $18.38 | 50 | $919 | 1.0% |
| 4 | $18.40 | 50 | $920 | 1.0% |
| 5 | $18.41 | 445 | $8K | 9.2% |
| 6 | $18.43 | 100 |
| $2K |
| 2.1% |
| 7 | $18.44 | 50 | $922 | 1.0% |
| 8 | $18.45 | 324 | $6K | 6.7% |
| 9 | $18.47 | 50 | $924 | 1.0% |
| 10 | $18.49 | 50 | $924 | 1.0% |
| 11 | $18.50 | 150 | $3K | 3.1% |
| 12 | $18.52 | 200 | $4K | 4.1% |
| 13 | $18.55 | 550 | $10K | 11.4% |
| 14 | $18.56 | 200 | $4K | 4.2% |
| 15 | $18.61 | 9 | $167 | 0.2% |
| 16 | $18.64 | 100 | $2K | 2.1% |
| 17 | $18.66 | 300 | $6K | 6.3% |
| 18 | $18.67 | 22 | $411 | 0.5% |
| 19 | $18.74 | 150 | $3K | 3.1% |
| 20 | $18.75 | 150 | $3K | 3.1% |
| 21 | $18.76 | 50 | $938 | 1.0% |
| 22 | $18.77 | 334 | $6K | 7.0% |
| 23 | $18.79 | 100 | $2K | 2.1% |
| 24 | $18.80 | 100 | $2K | 2.1% |
| 25 | $18.81 | 150 | $3K | 3.2% |
| 26 | $18.85 | 100 | $2K | 2.1% |
| 27 | $18.87 | 150 | $3K | 3.2% |
| 28 | $18.99 | 100 | $2K | 2.1% |
| 29 | $19.26 | 275 | $5K | 5.9% |
| 30 | $19.31 | 41 | $792 | 0.9% |
| Total | $18.63 avg | 4,800 | $89K | 100% |
| Filing → |
| BIOD | SELL | 2008-02-01 | $40K | — | Filing → |
| BIOD | SELL | 2008-01-31 | $20K | — | Filing → |
| BIOD | SELL | 2008-01-31 | $36K | — | Filing → |